IP Library Granted Patent US 11,407,773
Granted Patent B2
US 11,407,773 · App. 16/776,682 · Granted Aug 9, 2022

Reagents useful for synthesizing rhodamine-labeled oligonucleotides

Inventors: Scott C. Benson (Alameda, CA); Ruiming N. Zou (Foster City, CA); Krishna G. Upadhya (Union City, CA); Paul M. Kenney (Sunnyvale, CA); Jonathan M. Cassel (Half Moon Bay, CA)
Assignee: Applied Biosystems, LLC
C07F9/6561C07D311/96C07F9/242C07F9/2408C07F9/65312C07F9/65515C07F9/650952C07H19/04C07H21/04C09B11/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,407,773
App. No.
16/776,682
Granted
Aug 9, 2022
Kind
B2
Abstract

The present disclosure provides reagents that can be used to label synthetic oligonucleotides with rhodamine dyes or dye networks that contain rhodamine dyes.

Claims (43)

1. A method of synthesizing an oligonucleotide labeled with an energy transfer dye pair that comprises an N-protected NH-rhodamine dye moiety, comprising the steps of:

i. coupling a donor or an acceptor dye phosphoramidite reagent to a support-bound protected oligonucleotide;

ii. optionally coupling one or more linker phosphoramidite reagents to the oxidized product of step i; and

iii. coupling an acceptor or a donor dye phosphoramidite reagent to the oxidized product of step ii,

wherein the acceptor dye phosphoramidite reagent is an N-protected NH-rhodamine phosphoramidite reagent, and wherein the N-protected NH-rhodamine dye moiety comprises a structure selected from:

wherein LM represents a label moiety comprising the N-protected NH-rhodamine dye, PEP represents the phosphate ester precursor group, B represents a suitably protected nucleobase, L 2 represents a linker linking label moiety LM to nucleobase B, and further wherein the N-protected NH-rhodamine dye moiety of the labeling moiety comprises a structure chosen from structural formulae (IIIa):

wherein:

R′ is selected from R 3′ and hydrogen;

R″ is selected from R 6′ and hydrogen;

R 9 is an acyl protecting group;

R 1′ , R 2′ , R 2″ , R 4′ , R 4″ , R 5′ , R 5″ , R 7′ , R 7″ , R 8′ , R 4 , R 5 , R 6 , and R 7 , when taken alone, are each, independently of one another, chosen from hydrogen, lower alkyl, (C6-C14) aryl, (C7-C20) arylalkyl, 5-14 membered heteroaryl, 6-20 membered heteroarylalkyl, —R b and —(CH 2 ) x —R b , where x is an integer ranging from 1 to 10 and R b is chosen from —X, —OH, —OR a , —SH, —SR a , —NH 2 , —NHR a , —NR c R c , —N + R c R c R c , perhalo lower alkyl, trihalomethyl, trifluoromethyl, —B(OH) 3 , —B(OR a ) 3 , —B(OH)O − , —B(OR a ) 2 O − , —B(OH)(O − ) 2 , —B(OR a )(O − ) 2 , —P(OH) 2 , —P(OH)O − , —P(OR a ) 2 , —P(OR a )O − , —P(O)(OH) 2 , —P(O)(OH)O − , —P(O)(O − ) 2 , —P(O)(OR a ) 2 , —P(O)(OR a )O − , —P(O)(OH)(OR a ), —OP(OH) 2 , —OP(OH)O − , —OP(OR a ) 2 , —OP(OR a )O − , —OP(O)(OH) 2 , —OP(O)(OH)O − , —OP(O)(O − ) 2 , —OP(O)(OR a ) 2 , —OP(O)(OR a )O − , —OP(O)(OR a )(OH), —S(O) 2 O—, —S(O) 2 OH, —S(O) 2 R a , —C(O)H, —C(O)R a , —C(O)O − , —C(O)OH, —C(O)NH 2 , —C(O)NHR a , —C(O)NR c R c , —C(S)NH 2 , —C(O)NHR a , —C(O)NR c R c , —C(NH)NH 2 , —C(NH)NHR a , and —C(NH)NR c R c , where X is halo, each R a is, independently of the others, chosen from lower alkyl, (C6-C14) aryl, (C7-C20) arylalkyl, 5-14 membered heteroaryl and 6-20 membered heteroarylalkyl, and each R c is, independently of the others, an R a , or, alternatively, two R c bonded to the same nitrogen atom may be taken together with that nitrogen atom to form a 5- to 8-membered saturated or unsaturated ring that may optionally include one or more of the same or different ring heteroatoms, which are typically selected from O, N and S,

or, alternatively, R 1′ and R 2′ or R 7′ and R 8′ are taken together with the carbon atoms to which they are bonded to form an optionally substituted (C6-C14) aryl bridge and/or R 4′ and R 4″ and/or R 5′ and R 5″ are taken together with the carbon atoms to which they are bonded to form a benzo group; and

R 3′ and R 6′ , when taken alone, are each, independently of one another, chosen from lower alkyl, (C6-C14) aryl, (C7-C20) arylalkyl, 5-14 membered heteroaryl and 6-20 membered heteroarylalkyl, —R b and —(CH 2 ) x —R b , where x is an integer ranging from 1 to 10 and R b , or alternatively, R 3′ and R 2′ or R 4′ and/or R 6′ and R 5′ or R 7′ in the compounds of structural formula (IIIa),

with the proviso that at least one of R 2′ , R 4′ , R 5′ , R 7′ , R 5 or R 6 in the compounds structural formula (IIIa) comprises a group of the formula —Y—, wherein —Y— is chosen from —C(O)—, —S(O) 2 —, —S—, and —NH.

2. The method of claim 1 in which the donor dye phosphoramidite reagent is an O-protected fluorecein phosphoramidite reagent.

3. The method of claim 1 in which L 2 is selected from —C≡C—CH 2 —NH—, —C≡C—C(O)—, —CH═CH—NH—, —CH═CH—C(O)—, —C≡C—CH 2 —NH—C(O)—(CH 2 ) 1-6 —NH—, —CH═CH—C(O)—NH—(CH 2 ) 1-6 —NH—C(O)—, —C≡CH—CH 2 —O—CH 2 CH 2 —[O—CH 2 CH 2 ] 0-6 —NH—, —C≡C—C≡C—CH 2 —O—CH 2 CH 2 [O—CH 2 CH 2 ] 0-6 —NH—, —C≡C—(Ar) 1-2 —C≡C—CH 2 —O—CH 2 CH 2 —[O—CH 2 CH 2 ] 0-6 —NH—, —C≡C—(Ar) 1-2 —O—CH 2 CH 2 —[O—CH 2 CH 2 ] 0-6 —NH—, and —C≡C—(Ar) 1-2 —O—CH 2 CH 2 —[O—CH 2 CH 2 ] 0-6 —NH—, where each Ar represents, independently of the others, an optionally substituted monocyclic or polycyclic cycloalkylene, cycloheteroalkynene, arylene or heteroarylene group.

4. The method of claim 1 , in which at least one of R 1′ , R 2′ , R 2″ , R 4′ , R 4″ , R 5′ , R 5″ , R 7′ , R 7″ , R 8′ , R 4 , R 5 , R 6 , and R 7 is chosen from —R b and —(CH 2 ) x —R b .

5. The method of claim 1 , in which the N-protected NH-rhodamine dye moiety comprises a structure selected from structural formulae (IIIa.1), (IIIa.2):

wherein R′, R″, R 2′ , R 2″ , R 3′ , R 4′ , R 4″ , R 5′ , R 5″ , R 6′ , R 7′ , R 7″ , R 8′ , R 4 , R 5 , R 6 , R 7 , R 9 and Y are as previously defined in claim 1 .

6. The method of claim 1 in which the N-protected NH-rhodamine dye moiety has one or more applicable features chosen from:

R 4 and R 7 are each chloro;

(ii) R 1′ and R 8′ are each hydrogen;

(iii) R 1′ and R 2′ or R 7′ and R 8′ are taken together to form a benzo group;

(iv) R 2′ and R 7′ are each hydrogen or lower alkyl;

(v) R′ is R 3′ and R″ is R 6′ ; and

(vi) R′ is R 3′ , R″ is R 6′ , and R 3′ and R 6′ are taken together with a substituent group on an adjacent carbon atom to form a group selected from —CH 2 CH 2 —, —CH 2 CH 2 CH 2 —, —C(CH 3 ) 2 CH═C(CH 3 )—, —C(CH 3 ) 2 CH═CH—, —CH 2 —C(CH 3 ) 2 — and

7. The method of claim 1 in which the energy transfer dye label moiety is linked to the 3′- or 5′-hydroxyl of the oligonucleotide.

8. The method of claim 1 in which the energy transfer dye label moiety is linked to a nucleobase of the oligonucleotide.

9. The method of claim 1 in which the oligonucleotide labeled with an energy transfer dye is further labeled with a donor and/or acceptor moiety for the N-protected NH-rhodamine moiety.

10. The method of claim 9 in which the energy transfer dye label moiety comprises structural formula (VI):

A-Z 1 -Sp-Z 2 -D  (VI)

wherein A represents the N-protected NH-rhodamine moiety, D represents the donor moiety, Z 1 and Z 2 , which may be the same or different, represent a portion of a linkage contributed by a functional group F z , and Sp represents a spacing moiety.

11. The method of claim 10 in which A is selected from structural formula A.1 and D is selected from structural formula D.1, or A is selected from structural formula A.7 and D is selected from structural formula D.7;

wherein:

E 1 is selected from —NHR 9 , —NR 3′ R 9 and —OR 9b ;

E 2 is selected from —NHR 9 , —NR 6′ R 9 and —OR 9b ;

R 9b is R 9 ;

Y 1a , Y 1b , Y 2a , Y 2b , Y 3a and Y 3b are each, independently of one another, selected from —O—, —S—, —NH—, —C(O—) and —S(O) 2 —; and

R′, R″, R 2′ , R 2″ , R 3′ , R 4′ , R 4″ , R 5′ , R 5″ , R 6′ , R 7′ , R 7″ , R 8′ , R 4 , R 5 , R 6 , R 7 , and R 9 are as previously defined in claim 1 , with the proviso that when E 1 and E 2 are —OR 9b , then R 1′ and R 2′ and/or R 7′ and R 8′ may only be taken together with the carbon atoms to which they are bound to form an optionally substituted (C6-C14) aryl bridge.

12. The method of claim 11 in which A is selected from structural formula A.1.

13. The method of claim 1 in which the oligonucleotide labeled with an energy transfer dye is further labeled with a quencher moiety.

14. The method of claim 1 in which the oligonucleotide labeled with an energy transfer dye is further labeled with a minor groove binding moiety.

15. The method of claim 1 which further comprises the steps of deprotecting and cleaving the oligonucleotide labeled with an energy transfer dye from the support.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 12, 2020
From: BENSON, SCOTT C.; ZOU, RUIMING N.; UPADHYA, KRISHNA G.; KENNEY, PAUL M.; CASSEL, JONATHAN M.
To: APPLERA CORPORATION
Reel/Frame 052638/0348 →
MERGER Recorded May 12, 2020
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 052638/0367 →
MERGER AND CHANGE OF NAME Recorded May 12, 2020
From: APPLIED BIOSYSTEMS INC.; ATOM ACQUISITION, LLC
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 052638/0381 →
Continuity (5)
Division 15694279 · Sep 1, 2017
Division 14702499 · May 1, 2015
Division 11695548 · Apr 2, 2007
Provisional Application 60787777 · Mar 31, 2006
Related Publication 20200270287A1 · Aug 27, 2020